Average Co-Inventor Count = 3.70
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kyungpook National University Industry-academic Cooperation Foundation (8 from 337 patents)
2. Korea Institute of Science and Technology (3 from 2,169 patents)
3. Seoul National University (2 from 1,572 patents)
4. University of Ulsan (2 from 2 patents)
5. Pharosgen (2 from 2 patents)
6. Industrial Technology Research Institute (1 from 9,157 patents)
11 patents:
1. 11261236 - Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof
2. 10501549 - Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
3. 10202459 - Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
4. 9833464 - Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
5. 9605038 - Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis
6. 9409923 - Drug-fluorophore complex for specific detection of tumor cells
7. 8993721 - Peptides for targeting apoptotic cells and uses thereof
8. 8975369 - Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
9. 8748398 - Stroke-targeting peptide and use thereof
10. 8217012 - Peptides for targeting apoptotic cells and uses thereof
11. 7968081 - Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof